Diagnostic value of blood gene expression signatures in active tuberculosis in Thais: A pilot study

Genes and Immunity

Volumn 16, Issue 4, 2015, Pages 253-260

  Satproedprai, N ^a   Wichukchinda, N ^a   Suphankong, S ^a   Inunchot, W ^a   Kuntima, T ^b   Kumpeerasart, S ^a   Wattanapokayakit, S ^a   Nedsuwan, S ^c   Yanai, H ^d   Higuchi, K ^e,f   Harada, N ^e,f   Mahasirimongkol, S ^a  

^a Medical Life Sciences Institute   (Thailand)

^b TB HIV Research Foundation   (Thailand)

^c Chiangrai Prachanukroh Hospital   (Thailand)

^d Japan Anti Tuberculosis Association   (Japan)

^e RESEARCH INSTITUTE OF TUBERCULOSIS   (Japan)

^f Research Institute of Immune Diagnosis   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

APOL1 PROTEIN; ETHAMBUTOL; FCGR1A PROTEIN; FCGR1B VARIANT 1 PROTEIN; FCGR1B VARIANT 2 PROTEIN; GBP5 PROTEIN; ISONIAZID; KAZN PROTEIN; KCNJ15 PROTEIN; PROTEIN; PSTPIP2 PROTEIN; PYRAZINAMIDE; RIFAMPICIN; STAT1 PROTEIN; TRANSCRIPTION FACTOR MAFB; UNCLASSIFIED DRUG; APOL1 PROTEIN, HUMAN; APOLIPOPROTEIN; FC RECEPTOR; FCGR1A PROTEIN, HUMAN; HIGH DENSITY LIPOPROTEIN; MAFB PROTEIN, HUMAN; PLASMA PROTEIN; STAT1 PROTEIN, HUMAN; TUBERCULOSTATIC AGENT;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CHEMOTHERAPY; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC VALUE; DRUG TREATMENT FAILURE; FEMALE; GENE EXPRESSION; HUMAN; INTERFERON GAMMA RELEASE ASSAY; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; PILOT STUDY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SHORT COURSE THERAPY; SPUTUM CULTURE; THORAX RADIOGRAPHY; TREATMENT DURATION; TREATMENT OUTCOME; TUBERCULOSIS; BLOOD; CASE CONTROL STUDY; GENE EXPRESSION PROFILING; GENETICS; MIDDLE AGED; THAILAND; YOUNG ADULT;

THAIS;

ADULT; AGED; ANTITUBERCULAR AGENTS; APOLIPOPROTEINS; BLOOD PROTEINS; CASE-CONTROL STUDIES; FEMALE; GENE EXPRESSION PROFILING; HUMANS; LIPOPROTEINS, HDL; MAFB TRANSCRIPTION FACTOR; MALE; MIDDLE AGED; PILOT PROJECTS; RECEPTORS, IGG; STAT1 TRANSCRIPTION FACTOR; THAILAND; TUBERCULOSIS; YOUNG ADULT;

EID: 84930480194     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/gene.2015.4     Document Type: Article

References (35)

1. O'Garra A, Redford PS, McNab FW, Bloom CI, Wilkinson RJ, Berry MP. The immune response in tuberculosis. Ann Rev Immunol 2013; 31: 475-527.
2. Weyer K, Carai S, Nunn P. Viewpoint TB diagnostics: what does the world really need? J Infect Dis 2011; 204: S1196-S1202.
3. Berry MP, Graham CM, McNab FW, Xu Z, Bloch SA, Oni T et al. An interferoninducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 2010; 466: 973-977.
4. Maertzdorf J, Repsilber D, Parida SK, Stanley K, Roberts T, Black G et al. Human gene expression profiles of susceptibility and resistance in tuberculosis. Genes Immun 2011; 12: 15-22.
5. Jacobsen M, Repsilber D, Gutschmidt A, Neher A, Feldmann K, Mollenkopf HJ et al. Candidate biomarkers for discrimination between infection and disease caused by Mycobacterium tuberculosis. J Mol Med 2007; 85: 613-621.
6. Streimish I, Bizzarro M, Northrup V, Wang C, Renna S, Koval N et al. Neutrophil CD64 as a diagnostic marker in neonatal sepsis. Pediatr Infect Dis J 2012; 31: 777-781.
7. Roussel M, Gros A, Sauvadet E, Gacouin A, Marque S, Chimot L et al. CD64, a reliable biomarker of bacterial infection in intensive care units? Am J Resp Crit Care Med 2012; 186: 1058.
8. Li S, Huang X, Chen Z, Zhong H, Peng Q, Deng Y et al. Neutrophil CD64 expression as a biomarker in the early diagnosis of bacterial infection: a meta-analysis. Int J Infect Dis 2012; 17: e12-e23.
9. Fjaertoft G, Hakansson L, Ewald U, Foucard T, Venge P. Neutrophils from term and preterm newborn infants express the high affinity Fcgamma-receptor I (CD64) during bacterial infections. Pediatr Res 1999; 45: 871-876.
10. Bloom CI, Graham CM, Berry MP, Wilkinson KA, Oni T, Rozakeas F et al. Detectable changes in the blood transcriptome are present after two weeks of antituberculosis therapy. PLoS One 2012; 7: e46191.
11. Mahasirimongkol S, Yanai H, Mushiroda T, Promphittayarat W, Wattanapokayakit S, Phromjai J et al. Genome-wide association studies of tuberculosis in Asians identify distinct at-risk locus for young tuberculosis. J Hum Genet 2012; 57: 363-367.
12. Mahasirimongkol S, Yanai H, Nishida N, Ridruechai C, Matsushita I, Ohashi J et al. Genome-wide SNP-based linkage analysis of tuberculosis in Thais. Genes Immun 2009; 10: 77-83.
13. Parida SK, Kaufmann SH. The quest for biomarkers in tuberculosis. Drug Discov Today 2010; 15: 148-157.
14. Anderson ST, Kaforou M, Brent AJ, Wright VJ, Banwell CM, Chagaluka G et al. Diagnosis of childhood tuberculosis and host RNA expression in Africa. N Eng J Med 2014; 370: 1712-1723.
15. Bloom CI, Graham CM, Berry MP, Rozakeas F, Redford PS, Wang Y et al. Transcriptional blood signatures distinguish pulmonary tuberculosis, pulmonary sarcoidosis, pneumonias and lung cancers. PLoS One 2013; 8: e70630.
16. Cliff JM, Lee JS, Constantinou N, Cho JE, Clark TG, Ronacher K et al. Distinct phases of blood gene expression pattern through tuberculosis treatment reflect modulation of the humoral immune response. J Infect Dis 2013; 207: 18-29.
17. Jacobsen M, Mattow J, Repsilber D, Kaufmann SH. Novel strategies to identify biomarkers in tuberculosis. Biol Chem 2008; 389: 487-495.
18. Kaforou M, Wright VJ, Oni T, French N, Anderson ST, Bangani N et al. Detection of tuberculosis in HIV-infected and-uninfected African adults using whole blood RNA expression signatures: a case-control study. PLoS Med 2013; 10: e1001538.
19. Maertzdorf J, Ota M, Repsilber D, Mollenkopf HJ, Weiner J, Hill PC et al. Functional correlations of pathogenesis-driven gene expression signatures in tuberculosis. PLoS One 2011; 6: e26938.
20. Sutherland JS, Loxton AG, Haks MC, Kassa D, Ambrose L, Lee JS et al. Differential gene expression of activating Fcgamma receptor classifies active tuberculosis regardless of human immunodeficiency virus status or ethnicity. Clin Microbiol Infect 2014; 20: O230-O238.
21. Siberil S, Dutertre CA, Boix C, Bonnin E, Menez R, Stura E et al. Molecular aspects of human FcgammaR interactions with IgG: functional and therapeutic consequences. Immunol Lett 2006; 106: 111-118.
22. van der Poel CE, Spaapen RM, van de Winkel JG, Leusen JH. Functional characteristics of the high affinity IgG receptor, FcgammaRI. J Immunol 2011; 186: 2699-2704.
23. Xie T, Liang J, Liu N, Wang Q, Li Y, Noble PW et al. MicroRNA-127 inhibits lung inflammation by targeting IgG Fcgamma receptor I. J Immunol 2012; 188: 2437-2444.
24. Serezani CH, Aronoff DM, Sitrin RG, Peters-Golden M. FcgammaRI ligation leads to a complex with BLT1 in lipid rafts that enhances rat lung macrophage antimicrobial functions. Blood 2009; 114: 3316-3324.
25. Ridruechai C, Mahasirimongkol S, Phromjai J, Yanai H, Nishida N, Matsushita I et al. Association analysis of susceptibility candidate region on chromosome 5q31 for tuberculosis. Genes Immun 2010; 11: 416-422.
26. Sarrazin S, Mossadegh-Keller N, Fukao T, Aziz A, Mourcin F, Vanhille L et al. MafB restricts M-CSF-dependent myeloid commitment divisions of hematopoietic stem cells. Cell 2009; 138: 300-313.
27. Kim H, Seed B. The transcription factor MafB antagonizes antiviral responses by blocking recruitment of coactivators to the transcription factor IRF3. Nat Immunol 2010; 11: 743-750.
28. Smith EE, Malik HS. The apolipoprotein L family of programmed cell death and immunity genes rapidly evolved in primates at discrete sites of host-pathogen interactions. Genome Res 2009; 19: 850-858.
29. Pays E, Vanhollebeke B. Human innate immunity against African trypanosomes. Curr Opin Immunol 2009; 21: 493-498.
30. Wasser WG, Tzur S, Wolday D, Adu D, Baumstein D, Rosset S et al. Population genetics of chronic kidney disease: the evolving story of APOL1. J Nephrol 2012; 25: 603-618.
31. Hartman SE, Bertone P, Nath AK, Royce TE, Gerstein M, Weissman S et al. Global changes in STAT target selection and transcription regulation upon interferon treatments. Genes Dev 2005; 19: 2953-2968.
32. Monajemi H, Fontijn RD, Pannekoek H, Horrevoets AJ. The apolipoprotein L gene cluster has emerged recently in evolution and is expressed in human vascular tissue. Genomics 2002; 79: 539-546.
33. Zhaorigetu S, Wan G, Kaini R, Jiang Z, ApoL1 Hu CA. a BH3-only lipid-binding protein, induces autophagic cell death. Autophagy 2008; 4: 1079-1082.
34. Ding C, Peng H. Minimum redundancy feature selection from microarray gene expression data. J Bioinform Comput Biol 2005; 3: 185-205.
35. Friedman J, Hastie T, Tibshirani R. Regularization paths for generalized linear models via coordinate descent. J Stat Softw 2010; 33: 1-22.